Q: If a patient participating in a clinical trial is allergic to one of the drugs used in the trial, how do we report the drug that is used as a substitute?
The opioid crisis in the U.S. continues to touch on issues of patient rights and privacy. In October, OCR launched an education campaign about civil rights protections that include specific guidelines for covered entities under HIPAA
Advanced Care Hospitalists PL in Lakeland, Florida, has agreed to pay $500,000 and undergo a corrective action plan in a settlement with the HHS Office for Civil Rights (OCR) for its alleged violations of HIPAA’s Privacy and Security Rules.
A proposal to change discharge planning regulations has gotten new life. CMS announced last month that it is giving itself another year to publish the final version of the discharge planning rule.
This week's note from the instructor provides guidance on what type of information should be provided to patients during the informed consent process of clinical trials.
